Shen‐Liang Shih - Concepedia

Author

Shen‐Liang Shih

Kaohsiung Medical University Chung-Ho Memorial Hospital ORCID

Also Known As

Shen-Liang Shih, Shen-liang Shih, Shen‐Liang Shih

Publications

263

Citations

H-Index

Concepts

All Affiliations

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung Medical University Fooyin University I-Shou University

About

Shen‐Liang Shih is an author at Kaohsiung Medical University Chung-Ho Memorial Hospital specializing in tumor biology, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	77
2	Cell Biology	3	3	77
3	Pathology	2	2	64
4	Cellular Therapies	1	1	13
5	Immunology	1	1	13

Shen‐Liang Shih

Publications

210

Citations

H-Index

Page 1

	Year	Citations
Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer Ming‐Feng Hou, Fu Ou‐Yang, Chung-Liang Li, Experimental & Molecular Medicine	2021	62
FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer Jun‐Ping Shiau, Cheng-Che Wu, Shu‐Jyuan Chang, Biomedicines Zebrafish AngiogenesisBreast OncologyOncologyAngiogenesisMedicine	2021	44
Learned Resourcefulness, Quality of Life, and Depressive Symptoms for Patients With Breast Cancer Chiung‐Yu Huang, Su‐Er Guo, Chao‐Ming Hung, Oncology nursing forum	2010	36
Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats Shen‐Liang Shih, Yin-Shiou Lin, Shyr‐Yi Lin, Botanical studies	2015	20
Exosomal microRNA-92b Is a Diagnostic Biomarker in Breast Cancer and Targets Survival-Related MTSS1L to Promote Tumorigenesis Jung‐Yu Kan, Shen‐Liang Shih, Sheau‐Fang Yang, International Journal of Molecular Sciences Breast OncologyOncologyExosomal Microrna-92bExosomal MicrornasMedicine	2024	20
Comprehensive Transcriptomic Analysis Identifies ST8SIA1 as a Survival-Related Sialyltransferase Gene in Breast Cancer Jung‐Yu Kan, Sin‐Hua Moi, Wen‐Chun Hung, Genes	2020	15
Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer Cheng-Che Wu, Mei‐Ren Pan, Shen‐Liang Shih, Biomedicine & Pharmacotherapy Cell TherapyCancer ImmunosurveillanceFocal Adhesion KinaseBreast OncologyMedicine	2023	13

Page 1